The medication disclosure conversation before a girth enhancement consultation is one of the most important parts of the pre-procedure process — and one of the most commonly incomplete. Men sometimes omit medications they consider unrelated, supplements they don’t think count, or prescriptions they assume the provider will already know about. None of these assumptions are safe, and this post covers why.
Blood Thinners and Anticoagulants: The Most Urgent Category
Anticoagulants and antiplatelet medications are the medication category with the most direct relevance to injectable procedures of any kind. These drugs reduce the blood’s ability to clot, which increases bruising, prolongs any injection-site bleeding, and in the context of a filler procedure, can affect the distribution and stability of the filler in the tissue as it integrates.
Prescription Anticoagulants
Warfarin (Coumadin), rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and enoxaparin (Lovenox) are the most commonly prescribed anticoagulants in the patient population considering girth enhancement. These drugs exist for serious medical reasons — atrial fibrillation, pulmonary embolism history, deep vein thrombosis, mechanical heart valve — and they cannot be stopped or modified without direction from the prescribing physician. A provider who assesses your girth enhancement candidacy needs to know about any anticoagulant you take, because the management of anticoagulation around a procedure requires coordination with your prescribing physician, not just a personal decision to skip a dose before the appointment.
Antiplatelet Medications
Aspirin — even low-dose (81mg) daily aspirin taken for cardiovascular prevention — has measurable antiplatelet effects that persist for the lifespan of the platelet (7-10 days). Clopidogrel (Plavix), prasugrel (Effient), and ticagrelor (Brilinta) are prescription antiplatelets with similar or stronger effects. NSAIDs including ibuprofen (Advil, Motrin), naproxen (Aleve), and similar drugs have short-term antiplatelet effects that typically resolve within 24 hours of the last dose, but their regular use is worth disclosing. The relevance of any antiplatelet medication to a filler procedure is that increased bruising, injection-site oozing, and potential filler distribution changes are all possible consequences of antiplatelet effects during and after the procedure.
“The provider can’t make the right call on timing, dosing adjustment, or coordination with your other physicians if they don’t know what you’re taking. The medication disclosure isn’t paperwork — it’s part of the safety assessment.”
Supplements: The Underreported Category
Dietary supplements represent the medication category most commonly omitted from pre-procedure disclosures — either because patients don’t think of supplements as “medications,” because they assume over-the-counter status means no clinical relevance, or because they’ve listed them elsewhere and assume the information has been shared. None of these assumptions hold.
Supplements With Known Antiplatelet Effects
Fish oil (omega-3 fatty acids) at high doses — typically 3 grams or more per day — has measurable antiplatelet effects that can increase procedure-related bruising. Vitamin E at doses above 400 IU has similarly documented antiplatelet properties. Ginkgo biloba, garlic supplements, ginger at supplement doses (not culinary amounts), and turmeric/curcumin supplements all have documented effects on platelet function that are relevant to injectable procedures. These are not exotic supplements — they’re among the most commonly taken supplements in the male 35-65 demographic that includes most patients considering girth enhancement.
Herbal Supplements With Other Relevant Effects
St. John’s Wort (Hypericum perforatum) affects the metabolism of numerous medications through CYP450 enzyme induction — if you’re on other prescriptions while taking St. John’s Wort, your provider needs to know both, because the interaction may affect how your other medications are working. Valerian, kava, and other supplements with sedative properties are relevant if any sedation is used during the procedure. Supplements marketed for sexual enhancement often contain undisclosed active pharmaceutical ingredients — these are worth disclosing specifically because their active components (sometimes phosphodiesterase inhibitors, sometimes alpha-blockers) can have vascular effects relevant to the procedure.
Prescription Medications by Category
Beyond anticoagulants, several other prescription medication categories have specific relevance to a girth enhancement consultation.
Corticosteroids
Systemic corticosteroids — prednisone, methylprednisolone, dexamethasone taken orally or by injection for inflammatory conditions — affect immune function, wound healing, and skin integrity in ways that change the candidacy assessment for any injection procedure. Long-term corticosteroid use specifically affects tissue fragility and healing response. Topical corticosteroids applied to the general body are lower-relevance but worth mentioning if they’re used in the treatment area or nearby.
Immunosuppressant Medications
Medications that suppress the immune system — used for autoimmune conditions, post-transplant management, or other indications — affect the infection risk and healing response after any procedure that breaches the skin barrier. Methotrexate, azathioprine, mycophenolate, cyclosporine, and biologic medications (adalimumab/Humira, etanercept/Enbrel, and similar agents) all fall in this category. Their relevance is to the infection risk and healing assessment, not necessarily to candidacy itself — but the provider needs to know in order to assess risk appropriately and provide the right post-procedure monitoring guidance.
Medications Affecting Vascular Function
Phosphodiesterase-5 inhibitors (sildenafil/Viagra, tadalafil/Cialis, vardenafil/Levitra) affect penile vascular function in ways that are specifically relevant to a procedure in this anatomical area. They should be disclosed with the timing of the most recent dose, not just whether they’re “used sometimes.” Alpha-blockers (tamsulosin/Flomax, doxazosin/Cardura, alfuzosin/Uroxatral) prescribed for benign prostatic hyperplasia or hypertension have vascular effects that are relevant to the assessment. These are not disqualifying — they’re contextual information the provider needs for proper assessment and procedure planning.
Medications That May Require Temporary Discontinuation
Some medications that are relevant to the procedure can be temporarily held in the pre-procedure period — but this decision must be made by the prescribing physician, not by the patient acting on a general guideline they read online. The general categories where temporary pre-procedure discontinuation is sometimes discussed (with physician guidance) include low-dose aspirin taken for primary prevention (rather than secondary prevention in high-risk cardiovascular patients, where stopping aspirin carries its own risks), NSAIDs for non-urgent pain management, and non-prescription supplements with antiplatelet effects. Never stop a prescribed medication before a procedure without explicit guidance from the prescribing physician, even if you read that the medication category is relevant to the procedure. The risk of stopping a prescribed medication without physician guidance can exceed the procedural risk the medication would otherwise create.
Anticoagulants: warfarin, rivaroxaban, apixaban, dabigatran, enoxaparin — disclose all. Do not modify without prescribing physician direction.
Antiplatelets: daily aspirin (any dose), clopidogrel, prasugrel, ticagrelor — disclose all. Low-dose aspirin is still relevant.
NSAIDs: regular use of ibuprofen, naproxen, or similar. Disclose with typical frequency and last dose timing.
Supplements: fish oil, vitamin E, ginkgo biloba, garlic, turmeric/curcumin, St. John’s Wort, valerian, sexual enhancement supplements — disclose all.
Corticosteroids: oral, injected, or topical (if near treatment area).
Immunosuppressants: all, regardless of indication.
PDE-5 inhibitors: sildenafil, tadalafil, vardenafil — disclose with timing of last dose.
Any medication with uncertain relevance: disclose it. There is no downside to disclosing a medication that turns out not to matter. The downside of omitting a relevant one is significant.
For men in the Houston area who want to discuss their specific medication history and how it affects their candidacy for girth enhancement, expert penile enlargement in Houston provides the thorough consultation process designed to address exactly this kind of individualized medical history assessment. For the full picture of the clinic’s approach to candidacy and patient safety, the girth enlargement clinic is the right starting point.
Frequently Asked Questions
Do I need to stop taking aspirin before girth enhancement?
Whether to stop or hold aspirin before a girth enhancement procedure depends on why you’re taking aspirin and the specific guidance of both your prescribing physician and your girth enhancement provider. Low-dose daily aspirin taken for primary cardiovascular prevention (in patients without established cardiovascular disease) is sometimes held for 7-10 days before aesthetic procedures, since aspirin’s antiplatelet effects persist for the lifespan of the platelet. Low-dose aspirin taken for secondary prevention — in patients with established cardiovascular disease, prior heart attack, prior stent, or similar indications — carries its own risk if stopped, and stopping it requires explicit physician direction, not a personal judgment call before a cosmetic procedure. Disclose that you take aspirin, at what dose, and for what indication, and let the provider and your physician coordinate the appropriate guidance.
Are supplements really relevant to a girth enhancement consultation?
Yes. Supplements are frequently omitted from pre-procedure disclosures because patients don’t classify them as “medications,” but several commonly taken supplements have pharmacological effects that are directly relevant to injectable procedures. Fish oil at doses above 3 grams per day, vitamin E above 400 IU, ginkgo biloba, garlic supplements, and turmeric/curcumin supplements all have documented antiplatelet effects that can increase procedure-related bruising and affect the injection site response. These are among the most commonly taken supplements in the patient population considering this procedure, and their omission leaves the provider with an incomplete picture for assessing and managing procedural risk. Disclose all supplements — there’s no downside to disclosing something that turns out not to matter.
Should I tell my provider about medications for other conditions if they seem unrelated?
Yes, without filtering. The judgment of what’s relevant belongs to the provider doing the assessment, not to the patient deciding in advance what seems unrelated to a cosmetic procedure. Medications for hypertension, diabetes, thyroid conditions, depression, prostate conditions, and a wide range of other common health issues can have pharmacological effects that are relevant to a filler procedure’s safety profile — through mechanisms including vascular effects, immune effects, healing effects, or drug interactions with any topical numbing agents used during the procedure. The complete medication list is what allows the provider to make a complete and accurate assessment. Selective disclosure based on personal judgment about relevance is how relevant medications get omitted.
What happens if I forget to mention a medication at the consultation?
If you remember a medication you omitted from the consultation disclosure before the procedure date, contact the provider’s office to add it to your medical record and get guidance on whether it changes any pre-procedure instructions. If you remember at the procedure itself, tell the provider before the treatment begins — not after. An omitted medication that’s disclosed before the procedure begins can be assessed and managed; one that’s discovered after is a different situation. Most omissions don’t result in complications, but the ones that do are the reason the pre-procedure disclosure process exists. The burden of providing complete information is on the patient; the burden of knowing what to do with it is on the provider.
Can I take ibuprofen before my girth enhancement procedure?
Taking ibuprofen or other NSAIDs in the days before a girth enhancement procedure is generally not recommended, because NSAIDs have antiplatelet effects that increase bruising risk and can affect the injection-site response. The antiplatelet effects of ibuprofen are shorter-lived than aspirin — they typically resolve within 24 hours of the last dose — so the timing of the last NSAID dose relative to the procedure matters. Your provider’s pre-procedure instructions will include specific guidance on NSAID avoidance timing. If you’re taking NSAIDs for pain management and stopping them before the procedure creates a meaningful pain management problem, discuss this with your provider and prescribing physician rather than making the decision independently.
Do PDE-5 inhibitors like Viagra or Cialis affect girth enhancement candidacy?
PDE-5 inhibitors (sildenafil/Viagra, tadalafil/Cialis, vardenafil/Levitra) should be disclosed at the consultation, including how frequently you use them and the timing of the last dose relative to the procedure date. These medications affect penile vascular function in ways that are specifically relevant to a procedure in this anatomical area — they work by increasing blood flow through vasodilation of penile vasculature, which can affect tissue state during and immediately after the procedure. They’re not an automatic disqualifier, but the provider needs this information to assess the tissue state accurately and to provide appropriate pre-procedure timing guidance. Disclosing “I use tadalafil occasionally, last dose was X days ago” is the right level of specificity for the pre-procedure discussion.